Beyond weight loss, the expanding therapeutic landscape of GLP-1 agonists now includes cardiovascular risk reduction, peripheral artery disease management, and active clinical trials for neurodegenerative disorders and substance use disorderswith over 15 global trials underway for the latter indication alone
If the psychological impact of bloating is significant, consider taking measurements (waist circumference) at the same time each day, first thing in the morning before eating when bloating is typically at its minimum
The professional consensus in dermatology is: There is reasonable evidence for short-term brightening effects and antioxidant benefits at the cellular level Long-term safety and efficacy data are insufficient to make strong, universal clinical recommendations Medical supervision, appropriate dosing, and quality-controlled formulations are the essential safeguards that separate beneficial outcomes from adverse events WebMD's guide to glutathione provides a useful overview of potential risks and interactions for further reading
If IGF-1 remains below the age-adjusted lower quartile and the patient tolerates the dose without fluid retention or glucose elevation, increase to 100 to 150 mcg twice daily